SCHEMBL24867307

SCHEMBL24867307

O=C(O)CCc1ccc(Cl)cn1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 4/20 0.55
TSHR P16473 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
LMNA P02545 1/20 0.44
PLAU P00749 1/20 0.44
RXRA P19793 2/20 0.43
RXRB P28702 2/20 0.43
RXRG P48443 2/20 0.43
MAP4K4 O95819 1/20 0.43
P4HTM Q9NXG6 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
HPGD P15428 1/20 0.41
HTT P42858 1/20 0.41
GFER P55789 1/20 0.41
PTK2 Q05397 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3931024 0.89 RXRA (0.46) FFAR1TSHRL3MBTL1LMNAPLAU
SCHEMBL12984996 0.81 L3MBTL1 (0.44) TSHRL3MBTL1LMNAPLAUHTT
SCHEMBL19385660 0.80 CYP11B1 (0.49) TSHRL3MBTL1LMNAMAPTPTK2
SCHEMBL8414096 0.79 P4HTM (0.66) FFAR1L3MBTL1LMNAP4HTM
SCHEMBL3515895 0.78 FFAR1 (0.55) FFAR1TSHRL3MBTL1P4HTMKDM4E
SCHEMBL29009736 0.78 FFAR1 (0.55) FFAR1RXRARXRBRXRGP4HTM
SCHEMBL7996551 0.78 FFAR1 (0.55) FFAR1RXRARXRBRXRGMAP4K4
SCHEMBL29404687 0.78 FFAR1 (0.55) FFAR1RXRARXRBRXRGP4HTM
SCHEMBL25007407 0.78 FFAR1 (0.55) FFAR1TSHRL3MBTL1RXRARXRB
SCHEMBL2113281 0.78 FFAR1 (0.53) FFAR1LMNAPLAURXRARXRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12404265-B2 Substituted pyridine derivatives as SARM1 inhibitors NURA BIO, INC. (US) 2025-09-02 US disclosed
US-11970481-B1 Substituted pyridine derivatives as SARM1 inhibitors NURA BIO, INC. (US) 2024-04-30 US disclosed
US-20240116901-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS NURA BIO, INC. 2024-04-11 US disclosed
US-20230339913-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS NURA BIO, INC. 2023-10-26 US disclosed
US-20230339913-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS NURA BIO, INC. 2023-10-26 US disclosed
EP-4192828-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS Nura Bio, Inc. (US) 2023-06-14 EP disclosed
US-20230008433-A1 Inhibitors of SARM1 DISARM THERAPEUTICS, INC. 2023-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12404265-B2 Substituted pyridine derivatives as SARM1 inhibitors SARM1, SARNP, ADRM1 FFAR1 4246/4885TSHR 4223/4885L3MBTL1 949/4885
US-11970481-B1 Substituted pyridine derivatives as SARM1 inhibitors SARM1, SARNP, ADRM1 FFAR1 4246/4885TSHR 4223/4885L3MBTL1 949/4885
US-20230339913-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS SARM1, SARNP, ADRM1 FFAR1 4246/4885TSHR 4223/4885L3MBTL1 949/4885
US-20230008433-A1 Inhibitors of SARM1 SARM1, SMN1; SMN2, SARNP FFAR1 3754/4885TSHR 3994/4885L3MBTL1 186/4885
US-20240116901-A1 SUBSTITUTED PYRIDINE DERIVATIVES AS SARM1 INHIBITORS SARM1, SARNP, ADRM1 FFAR1 4246/4885TSHR 4223/4885L3MBTL1 949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.